Therese Andersson
About me
I am a biostatistician, working with statistical methods for cancer epidemiology. My main research interest is cancer patient survival and I have published studies on cancer patient survival for a range of cancer sites. I have also worked on international benchmarking of cancer patient survival, for example the International Cancer Benchmarking Partnership SURVMARK-2, run by the International Agency for Research on Cancer (IARC) and in a Nordic collaborative project. I develop statistical methods as well as apply the methods to register-based data to answer important epidemiological and clinical research questions. I’m currently working in several projects, a description of two projects I'm heavily involved with currently are described below.
Research
*Loss in life expectancy due to cancer*
One useful summary measure for survival data is the life expectancy, which is
calculated by obtaining the area under a survival curve. Life expectancy is a
well-established, easily understood concept that quantifies the expected
number of life years remaining. In comparison to many other measures, it
takes the whole time scale into account instead of at particular points
during follow-up (such as the 1- or 5-year survival). Another statistic,
closely related to the life expectancy, is the loss in life expectancy (LLE),
a measure of how much a patient's life expectancy is reduced due to a cancer
diagnosis. The LLE is defined as the difference in life expectancy between
the cancer patients and a comparable group in the general population. The
LLE can be used to address a wide range of research questions on both
individual and population levels, and to quantify survival differences
between groups. Another use of LLE is to quantify the burden of cancer on
society as the total number of life years lost in the population; in this
way, it can be useful for measuring cancer control progress and to provide
guidance for resource allocation. I have developed methods for estimating the
LLE for cancer patients, and further extend and evaluate the methodology to
enable use of the measure in different contexts.
*Survival after hematological cancers, with a focus on MPN*
Compared to many other hematological
malignancies MPNs are rather indolent diseases. Despite efforts to optimize
treatment and prophylactic measures, patients with MPNs have a shorter
survival than the general population and experience complications, such as
thromboembolism and bleedings, due to their MPN. There are few
population-based studies on MPNs, and most studies are small with short
follow-up time and do not include population controls. It is therefore of
great importance to gain a further understanding of the disease trajectory
and risk of complications for this group of patients. By taking advantage of
the Swedish health registers and novel statistical methods, we will improve
the understanding of the clinical course and prognosis among MPN patients.
Teaching
I have been involved in teaching and/or course organising, for example:
* Development of a MSc programme in Biostatistics and Data Science given within the Stockholm Trio, i.e. Karolinska Institutet, KTH Royal Institute of Technology and Stockholm University.
* Survival analysis (biostat III), within the Doctoral Programme in
Epidemiology
* Data Management within epidemiological research, including lectures on
laws and regulations concerning the use of personal data in research
* Competing risks and multistate models
* IARC summer school on cancer epidemiology, module 1, cancer survival
methods for cancer registries.
* Summer school on modern methods in biostatistics and epidemiology.
Survival analysis using Stata (a 1-day course) and Statistical Methods for
Population-based Cancer Survival (a 1-week course). Treviso, Italy.
* Workshops on epidemiological designs and cancer survival analysis
* Pre-conference courses on Statistical Methods for Population-based Cancer
Survival
* Biostatistics/evidence based medicine within the medical program at KI
Articles
- Article: SCANDINAVIAN JOURNAL OF SURGERY. 2025;:14574969251364947Zoltek M; Andersson TM-L; Hedman C; Nordenvall C; Lundgren CI
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2025;34(7):1141-1148Lambert PC; Andersson TML; Myklebust TA; Moller B; Rutherford MJ
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2025;207(1):189-200Batyrbekova N; Hultcrantz M; Ravn Landtblom A; Szulkin R; Dickman PW; Andersson TM-L; Syriopoulou E
- Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2025;54(4):dyaf082Larsen SB; Lundberg FE; Friis S; Birgisson H; Andersson TML; Engholm G; Lambert PC; Brasso K; Pettersson D; Olafsdottir E; Johannesen TB; Konig SM; Johansson ALV; Morch LS
- Article: BRITISH JOURNAL OF CANCER. 2025;132(8):673-678Stannard R; Lambert PC; Lyratzopoulos G; Andersson TM-L; Khan S; Rutherford MJ
- Article: ACTA ONCOLOGICA. 2025;64:585-594Osterman E; Syriopoulou E; Martling A; Andersson TM-L; Nordenvall C
- Journal article: SKIN CANCER. 2025;3:100357Krakowski I; Häbel H; Nielsen K; Andersson TM-L; Eriksson H
- Article: HEMASPHERE. 2024;8(7):e121Abalo KD; Ekberg S; Andersson TML; Pahnke S; Albertsson-Lindblad A; Smedby KE; Jerkeman M; Glimelius I
- Article: LUNG CANCER. 2024;192:107826Lundberg FE; Ekman S; Johansson ALV; Engholm G; Birgisson H; Olafsdottir EJ; Morch LS; Johannesen TB; Andersson TM-L; Pettersson D; Seppa K; Virtanen A; Lambe M; Lambert PC
- Article: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2024;78(6):402-408Syriopoulou E; Osterman E; Miething A; Nordenvall C; Andersson TM-L
- Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024;90(5):963-969Vikstrom S; Syriopoulou E; Andersson TM-L; Eriksson H
- Article: EUROPEAN JOURNAL OF CANCER. 2024;202:113980Lundberg FE; Birgisson H; Engholm G; Olafsdottir EJ; Morch LS; Johannesen TB; Pettersson D; Lambe M; Seppa K; Lambert PC; Johansson ALV; Holmichj LR; Andersson TM-L
- Article: LEUKEMIA. 2024;38(5):1081-1085Landtblom AR; Andersson TM-L; Johansson ALV; Lundberg FE; Samuelsson J; Bjorkholm M; Hultcrantz M
- Article: SCIENTIFIC REPORTS. 2024;14(1):8577Palshof FK; Morch LS; Koster B; Engholm G; Storm HH; Andersson TM-L; Kroman N
- Article: ACTA ONCOLOGICA. 2024;63:179-191Johansson ALV; Konig SM; Laronningen S; Engholm G; Kroman N; Seppa K; Malila N; Steig BA; Gudmundsdottir EM; Olafsdottir EJ; Lundberg FE; Andersson TM-L; Lambert PC; Lambe M; Pettersson D; Aagnes B; Friis S; Storm H
- Journal article: EUROPEAN JOURNAL OF CANCER. 2024;201:113940Osterman E; Syriopoulou E; Martling A; Andersson; Nordenvall C
- Article: EUROPEAN JOURNAL OF CANCER. 2024;199:113572Osterman E; Syriopoulou E; Martling A; Andersson TML; Nordenvall C
- Article: COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION. 2024;53(2):993-1006Batyrbekova N; Bower H; Dickman PW; Szulkin R; Lambert PC; Andersson TM-L
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2023;23(1):291Leontyeva Y; Lambe M; Bower H; Lambert PC; Andersson TM-L
- Article: BRITISH JOURNAL OF CANCER. 2023;129(5):819-828Myklebust TA; Aagnes B; Nilssen Y; Rutherford M; Lambert PC; Andersson TML; Johansson ALV; Dickman PW; Moller B
- Article: JNCI CANCER SPECTRUM. 2023;7(3):pkad038Radkiewicz C; Andersson TM-L; Lagergren J
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2023;23(1):87Skourlis N; Crowther MJ; Andersson TM-L; Lu D; Lambe M; Lambert PC
- Article: ACTA ONCOLOGICA. 2023;62(2):103-109Wiken I; Andersson TM-L; Radkiewicz C
- Article: BRITISH JOURNAL OF DERMATOLOGY. 2023;188(1):32-40Krakowski I; Habel H; Nielsen K; Ingvar C; Andersson TML; Girnita A; Smedby KE; Eriksson H
- Article: ACTA ONCOLOGICA. 2022;61(12):1481-1489Lundberg FE; Kroman N; Lambe M; Andersson TM-L; Engholm G; Johannesen TB; Virtanen A; Pettersson D; Olafsdottir EJ; Birgisson H; Lambert PC; Morch LS; Johansson ALV
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):290Batyrbekova N; Bower H; Dickman PW; Ravn Landtblom A; Hultcrantz M; Szulkin R; Lambert PC; Andersson TM-L
- Article: BRITISH JOURNAL OF CANCER. 2022;127(10):1808-1815Syriopoulou E; Wasterlid T; Lambert PC; Andersson TM-L
- Article: ACTA ONCOLOGICA. 2022;61(11):1377-1385Khoshkar Y; Vigneswaran HTT; Eloranta S; Andersson TM-L; Schain F; Boman A; Dahlkild M; Liwing J; Leval A; Akre O; Aly M
- Article: BRITISH JOURNAL OF CANCER. 2022;127(6):1061-1068Stannard R; Lambert PC; Andersson TM-L; Rutherford MJ
- Article: LEUKEMIA. 2022;36(10):2461-2467Landtblom AR; Andersson TM-L; Johansson ALV; Wendel SB; Lundberg FE; Samuelsson J; Bjorkholm M; Hultcrantz M
- Article: BIOMETRICAL JOURNAL. 2022;64(7):1161-1177Skourlis N; Crowther MJ; Andersson TM-L; Lambert PC
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2022;31(9):1720-1726Andersson TM-L; Rutherford MJ; Moller B; Lambert PC; Myklebust TA
- Article: STATA JOURNAL. 2022;22(3):679-701Bower H; Andersson TM-L; Crowther MJ; Lambert PC
- Article: EUROPEAN JOURNAL OF CANCER. 2022;172:76-84Lundberg FE; Birgisson H; Johannesen TB; Engholm G; Virtanen A; Pettersson D; Olafsdottir EJ; Lambe M; Lambert PC; Morch LS; Johansson ALV; Andersson TM-L
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2022;31(6):1168-1175Dasgupta P; Andersson TM-L; Garvey G; Baade PD
- Article: CANCERS. 2022;14(10):2349Zoltek M; Andersson TM-L; Axelsson E; Hedman C; Lundgren CI
- Article: BRITISH JOURNAL OF CANCER. 2022;126(8):1224-1228Andersson TM-L; Myklebust TA; Rutherford MJ; Moller B; Arnold M; Soerjomataram I; Bray F; Parkin DM; Lambert PC
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):130Leontyeva Y; Bower H; Gauffin O; Lambert PC; Andersson TM-L
- Article: BREAST CANCER RESEARCH. 2022;24(1):15Syriopoulou E; Gasparini A; Humphreys K; Andersson TM-L
- Article: CANCER EPIDEMIOLOGY. 2022;76:102085Andersson TM-L; Rutherford MJ; Myklebust TA; Moller B; Arnold M; Soerjomataram I; Bray F; Abd Elkader H; Engholm G; Huws D; Little A; Shack L; Walsh PM; Woods RR; Parkin DM; Lambert PC
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):2Rutherford MJ; Andersson TM-L; Myklebust TA; Moller B; Lambert PC
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2021;21(1):262Skourlis N; Crowther MJ; Andersson TM-L; Lambert PC
- Article: BREAST CANCER RESEARCH. 2021;23(1):109Boucheron P; Anele A; Zietsman A; Galukande M; Parham G; Pinder LF; Andersson TM-L; Anderson BO; Foerster M; Schuz J; Silva IDS; McCormack V
- Article: COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION. 2021;50(11):3777-3793Bower H; Crowther MJ; Rutherford MJ; Andersson TM-L; Clements M; Liu X-R; Dickman PW; Lambert PC
- Article: JOURNAL OF CLINICAL EPIDEMIOLOGY. 2021;137:92-103Qaderi SM; Andersson TML; Dickman PW; de Wilt JHW; Verhoeven RHA
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2021;55(4):299-306Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Eklund M; Nordstrom T; Eloranta S; Schain F; Dearden L; Liwing J; Mehra M; Nair S; Pettersson A; Akre O; Aly M
- Article: ARCHIVES OF SUICIDE RESEARCH. 2021;25(3):424-438Reutfors J; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Brenner P
- Article: CANCERS. 2021;13(10):2456Eriksson H; Utjes D; Olofsson Bagge R; Gillgren P; Isaksson K; Lapins J; Schultz IL; Lyth J; Andersson TM-L
- Article: STATISTICS IN MEDICINE. 2021;40(9):2139-2154Weibull CE; Lambert PC; Eloranta S; Andersson TML; Dickman PW; Crowther MJ
- Article: CANCER EPIDEMIOLOGY. 2021;71(Pt A):101881Andersson TM-L; Myklebust TA; Rutherford MJ; Moller B; Soerjomataram I; Arnold M; Bray F; Parkin DM; Sasieni P; Bucher O; De P; Engholm G; Gavin A; Little A; Porter G; Ramanakumar AV; Saint-Jacques N; Walsh PM; Woods RR; Lambert PC
- Article: BRITISH JOURNAL OF CANCER. 2021;124(5):1026-1032Andersson TM-L; Rutherford MJ; Myklebust TA; Moller B; Soerjomataram I; Arnold M; Bray F; Parkin DM; Sasieni P; Bucher O; De P; Engholm G; Gavin A; Little A; Porter G; Ramanakumar AV; Saint-Jacques N; Walsh PM; Woods RR; Lambert PC
- Article: LEUKEMIA. 2021;35(2):476-484Landtblom AR; Andersson TM-L; Dickman PW; Smedby KE; Eloranta S; Batyrbekova N; Samuelsson J; Bjorkholm M; Hultcrantz M
- Article: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY. 2021;11:20451253211006508Brenner P; Reutfors J; Nijs M; Andersson TM-L
- Article: BIOMETRICS. 2020;76(4):1053-1063Gabriel EE; Sachs MC; Follmann DA; Andersson TM-L
- Article: ACTA ONCOLOGICA. 2020;59(11):1266-1274Lundberg FE; Andersson TM-L; Lambe M; Engholm G; Morch LS; Johannesen TB; Virtanen A; Pettersson D; olafsdottir EJ; Birgisson H; Johansson ALV; Lambert PC
- Article: ACTA ONCOLOGICA. 2020;59(11):1322-1328Lambe M; Wigertz A; Sandin F; Holmberg E; Amsler-Nordin S; Andersson TM-L; Pettersson D
- Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2020;49(5):1614-1623Lambert PC; Andersson TM-L; Rutherford MJ; Myklebust TA; Moller B
- Article: CANCER RESEARCH. 2020;80(16):3436-3442Liu Q; Song H; Andersson TM-L; Magnusson PKE; Zhu J; Smedby KE; Fang F
- Article: CANCER EPIDEMIOLOGY. 2020;67:101759Myklebust TA; Andersson T; Bardot A; Vernon S; Gavin A; Fitzpatrick D; Jerm MB; Rutherford M; Parkin DM; Sasieni P; Arnold M; Soerjomataram I; Bray F; Lambert PC; Moller B
- Article: CLINICAL EPIDEMIOLOGY. 2020;12:737-744Hajiebrahimi M; Song C; Hagg D; Andersson TM-L; Villacorta R; Linder M
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748Wasterlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
- Journal article: INVESTIGATIVE UROLOGY. 2020;203(Supplement 4)Vigneswaran* HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
- Article: CANCER EPIDEMIOLOGY. 2020;65:101686Kou K; Dasgupta P; Cramb SM; Yu XQ; Andersson TM-L; Baade PD
- Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(4):448-454Hultcrantz M; Landtblom AR; Andreasson B; Samuelsson J; Dickman PW; Kristinsson SY; Bjorkholm M; Andersson TM-L
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2020;20(1):71Jakobsen LH; Andersson TM-L; Biccler JL; Poulsen LO; Severinsen MT; El-Galaly TC; Bogsted M
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(2):115-121Aly M; Leval A; Schain F; Liwing J; Lawson J; Vago E; Nordstrom T; Andersson TM-L; Sjoland E; Wang C; Eloranta S; Akre O
- Article: WORLD JOURNAL OF SURGERY. 2020;44(2):436-441Zoltek M; Andersson TM-L; Hedman C; Ihre-Lundgren C; Nordenvall C
- Article: CLINICAL EPIDEMIOLOGY. 2019;11:1025-1034Liu Q; Andersson TM; Joud A; Shen Q; Schelin MEC; Magnusson PKE; Smedby KE; Fang F
- Article: STATISTICAL METHODS IN MEDICAL RESEARCH. 2019;28(12):3822-3842Isheden G; Abrahamsson L; Andersson T; Czene K; Humphreys K
- Article: LANCET ONCOLOGY. 2019;20(11):1493-1505Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM-L; Myklebust TA; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Moller B; Soerjomataram I; Bray F
- Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(5):1200-1208Weibull CE; Bjorkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2019;19(1):145Andersson TM-L; Rutherford MJ; Lambert PC
- Article: BREAST. 2019;45:75-81Bower H; Andersson TM-L; Syriopoulou E; Rutherford MJ; Lambe M; Ahlgren J; Dickman PW; Lambert PC
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):703-713Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fossa A; Andersson TML; Holte H; Bogsted M; El-Galaly TC; Smedby KE
- Article: EUROPEAN JOURNAL OF CANCER. 2019;110:42-48Andersson TM-L; Engholm G; Lund A-SQ; Lourenco S; Matthiessen J; Pukkala E; Stenbeck M; Tryggvadottir L; Weiderpass E; Storm H
- Article: PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE. 2019;35(2):78-86Koster B; Meyer MKH; Andersson TM-L; Engholm G; Dalum P
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2019;19(1):23Jakobsen LH; Andersson TM-L; Biccler JL; El-Galaly TC; Bogsted M
- Article: EUROPEAN JOURNAL OF CANCER. 2018;103:288-298Andersson TM-L; Engholm G; Brink A-L; Pukkala E; Stenbeck M; Tryggvadottir L; Weiderpass E; Storm H
- Article: EUROPEAN JOURNAL OF CANCER. 2018;103:299-307Andersson TM-L; Engholm G; Pukkala E; Stenbeck M; Tryggvadottir L; Storm H; Weiderpass E
- Article: LEUKEMIA. 2018;32(10):2203-2210Landtblom AR; Bower H; Andersson TM-L; Dickman PW; Samuelsson J; Bjorkholm M; Kristinsson SY; Hultcrantz M
- Article: MEDICINE. 2018;97(41):e12738Koster B; Meyer M; Andersson T; Engholm G; Dalum P
- Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;238:674-679Reutfors J; Andersson TM-L; Brenner P; Brandt L; DiBernardo A; Li G; Hagg D; Wingard L; Boden R
- Article: BMJ OPEN. 2018;8(8):e022094Koster B; Meyer MKH; Andersson TM-L; Engholm G; Dalum P
- Journal article: ANNALS OF INTERNAL MEDICINE. 2018;169(4):268Hultcrantz M; Bjorkholm M; Landgren O; Kristinsson SY; Andersson TML
- Article: CANCER EPIDEMIOLOGY. 2018;55:1-7Lourenco S; Gunge VB; Andersson TM-L; Andersen CLE; Lund A-SQ; Koster B; Hansen GL
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(8):1020-1028Ekberg S; Jerkeman M; Andersson P-O; Enblad G; Wahlin BE; Hasselblom S; Andersson TM; Eloranta S; Smedby KE
- Article: INTERNATIONAL JOURNAL OF CANCER. 2018;142(7):1343-1354Johansson ALV; Andersson TM-L; Hsieh C-C; Jirstrom K; Cnattingius S; Fredriksson I; Dickman PW; Lambe M
- Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2018;187(4):828-836Bower H; Andersson TM-L; Crowther MJ; Dickman PW; Lambe M; Lambert PC
- Article: ANNALS OF INTERNAL MEDICINE. 2018;168(5):317-325Hultcrantz M; Bjorkholm M; Dickman PW; Landgren O; Derolf AR; Kristinsson SY; Andersson TML
- Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;186(9):1065-1073Andersson TM-L; Crowther MJ; Czene K; Hall P; Humphreys K
- Article: BRITISH JOURNAL OF CANCER. 2017;117(9):1419-1426Syriopoulou E; Bower H; Andersson TM-L; Lambert PC; Rutherford MJ
- Article: EUROPEAN JOURNAL OF CANCER. 2017;79:106-118Andersson TM-L; Weiderpass E; Engholm G; Lund A-SQ; Olafsdottir E; Pukkala E; Stenbeck M; Storm H
- Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(6):696-697Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
- Article: CANCER EPIDEMIOLOGY. 2017;46:50-56Andersson TM-L; Rutherford MJ; Humphreys K
- Article: BMC CANCER. 2017;17(1):2Song H; Fang F; Valdimarsdottir U; Lu D; Andersson TM-L; Hultman C; Ye W; Lundell L; Johansson J; Nilsson M; Lindblad M
- Article: INTERNATIONAL JOURNAL OF CANCER. 2017;140(1):34-40Strand F; Humphreys K; Eriksson M; Li J; Andersson TML; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
- Article: JAMA ONCOLOGY. 2016;2(9):1188-1196Lu D; Andersson TML; Fall K; Hultman CM; Czene K; Valdimarsdottir U; Fang F
- Article: CANCER CAUSES & CONTROL. 2016;27(8):955-964Baade PD; Youlden DR; Andersson TM; Youl PH; Walpole ET; Kimlin MG; Aitken JF; Biggar RJ
- Article: INTERNATIONAL JOURNAL OF CANCER. 2016;138(12):2829-2836Eriksson H; Lyth J; Andersson TM-L
- Article: BLOOD CANCER JOURNAL. 2016;6(2):e390Bower H; Andersson TM-L; Bjorkholm M; Dickman PW; Lambert PC; Derolf AR
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2015;90(12):1128-1134Glimelius I; Ekberg S; Jerkeman M; Chang ET; Bjorkholm M; Andersson TML; Smedby KE; Eloranta S
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2015;33(20):2288-2295Hultcrantz M; Wilkes SR; Kristinsson SY; Andersson TM-L; Derolf AR; Eloranta S; Samuelsson J; Landgren O; Dickman PW; Lambert PC; Bjorkholm M
- Article: CANCER. 2015;121(12):2072-2077Andersson TM-L; Johansson ALV; Fredriksson I; Lambe M
- Article: BMC CANCER. 2015;15:412Andersson TM-L; Dickman PW; Eloranta S; Sjovall A; Lambe M; Lambert PC
- Article: BREAST CANCER RESEARCH AND TREATMENT. 2015;151(1):209-217Johansson ALV; Andersson TM-L; Hsieh C-C; Cnattingius S; Dickman PW; Lambe M
- Article: BMJ OPEN. 2015;5(4):e006740Estimating the change in life expectancy after a diagnosis of cancer among the Australian populationBaade PD; Youlden DR; Andersson TM-L; Youl PH; Kimlin MG; Aitken JF; Biggar RJ
- Article: NEUROBIOLOGY OF AGING. 2015;36(4):1751-1756Karlsson IK; Bennet AM; Ploner A; Andersson TM-L; Reynolds CA; Gatz M; Pedersen NL
- Article: CANCER EPIDEMIOLOGY. 2015;39(1):118-125Rutherford MJ; Andersson TM-L; Moller H; Lambert PC
- Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2014;71(6):1093-1101Johansson ALV; Andersson TM-L; Plym A; Ullenhag GJ; Moller H; Lambe M
- Article: EPIDEMIOLOGY. 2014;25(5):742-748Eloranta S; Lambert PC; Andersson TM-L; Bjorkholm M; Dickman PW
- Article: BMC CANCER. 2014;14:391Holmes MD; Olsson H; Pawitan Y; Holm J; Lundholm C; Andersson TM-L; Adami H-O; Askling J; Smedby KE
- Article: CANCER EPIDEMIOLOGY. 2014;38(1):93-99Andersson TM-L; Eriksson H; Hansson J; Mansson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
- Article: STATISTICS IN MEDICINE. 2013;32(30):5286-5300Andersson TM-L; Dickman PW; Eloranta S; Lambe M; Lambert PC
- Article: CANCER EPIDEMIOLOGY. 2013;37(6):836-842Yu XQ; De Angelis R; Andersson TML; Lambert PC; O'Connell DL; Dickman PW
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2013;162(4):509-516Shah A; Andersson TM-L; Rachet B; Bjorkholm M; Lambert PC
- Article: BREAST CANCER RESEARCH AND TREATMENT. 2013;139(1):183-192Johansson ALV; Andersson TM-L; Hsieh C-C; Jirstrom K; Dickman P; Cnattingius S; Lambe M
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2013;31(11):1435-1441Eloranta S; Lambert PC; Sjoberg J; Andersson TML; Bjorkholm M; Dickman PW
- Article: CANCER CAUSES & CONTROL. 2013;24(3):505-515Eloranta S; Adolfsson J; Lambert PC; Stattin P; Akre O; Andersson TM-L; Dickman PW
- Article: LAKARTIDNINGEN. 2013;110(8):416-419Eloranta S; Johansson ALV; Kristinsson SY; Andersson TM-L
- Article: JOURNAL OF NUTRITIONAL SCIENCE. 2013;2:e15Moller E; Galeone C; Andersson TM-L; Bellocco R; Adami H-O; Andren O; Gronberg H; La Vecchia C; Mucci LA; Balter K
- Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(1):155-161Nordenvall C; Nilsson PJ; Ye W; Andersson TM-L; Nyren O
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2013;88(1):60-65Kristinsson SY; Eloranta S; Dickman PW; Andersson TM-L; Turesson I; Landgren O; Bjorkholm M
- Article: STATA JOURNAL. 2012;12(4):623-638Andersson TM-L; Lambert PC
- Article: PUBLIC HEALTH NUTRITION. 2012;15(10):1897-1908Moller E; Galeone C; Adami H-O; Adolfsson J; Andersson TM-L; Bellocco R; Gronberg H; Mucci LA; Balter K
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(24):2995-3001Hultcrantz M; Kristinsson SY; Andersson TM-L; Landgren O; Eloranta S; Derolf AR; Dickman PW; Bjorkholm M
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2012;12:86Eloranta S; Lambert PC; Andersson TML; Czene K; Hall P; Bjorkholm M; Dickman PW
- Article: JOURNAL OF TRAUMA AND ACUTE CARE SURGERY. 2012;72(4):954-960Norda R; Andersson TM-L; Edgren G; Nyren O; Reilly M
- Journal article: BMJ-BRITISH MEDICAL JOURNAL. 2012;344Andrae B; Andersson TM-L; Lambert PC; Kemetli L; Silfverdal L; Strander B; Ryd W; Dillner J; Tornberg S; Sparen P
- Article: BMJ-BRITISH MEDICAL JOURNAL. 2012;344:e900Andrae B; Andersson TM-L; Lambert PC; Kemetli L; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S; Sparén P
- Journal article: BLOOD. 2011;118(21):3855Hultcrantz ML; Hinchliffe SR; Kristinsson SY; Andersson TM-L; Eloranta S; Derolf ÅR; Samuelsson J; Landgren O; Dickman PW; Lambert P; Björkholm M
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2011;20(9):1865-1872Johansson ALV; Andersson TM-L; Hsieh C-C; Cnattingius S; Lambe M
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2011;11:96Andersson TML; Dickman PW; Eloranta S; Lambert PC
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(18):2514-2520Bjorkholm M; Ohm L; Eloranta S; Derolf A; Hultcrantz M; Sjoberg J; Andersson T; Hoglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2011;20(2):308-317Hedelin M; Lof M; Andersson TM-L; Adlercreutz H; Weiderpass E
- Journal article: BLOOD. 2010;116(21):205Bjorkholm M; Ohm L; Eloranta S; Derolf ÅR; Hultcrantz M; Sjöberg J; Andersson T; Hoglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
- Article: EUROPEAN JOURNAL OF CANCER. 2010;46(16):2965-2972Eloranta S; Lambert PC; Cavalli-Bjorkman N; Andersson TM-L; Glimelius B; Dickman PW
- Article: AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS. 2010;153B(6):1160-1166Sim SC; Nordin L; Andersson TM-L; Virding S; Olsson M; Pedersen NL
- Article: TRANSFUSION. 2010;50(6):1249-1256Tynell E; Andersson TML; Norda R; Edgren G; Nyren O; Shanwell A; Reilly M
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;148(6):918-924Andersson TM-L; Lambert PC; Derolf AR; Kristinsson SY; Eloranta S; Landgren O; Bjorkholm M; Dickman PW
- Article: HAEMATOLOGICA. 2009;94(12):1714-1720Kristinsson SY; Bjorkholm M; Andersson TM-L; Eloranta S; Dickman PW; Goldin LR; Blimark C; Mellqvist U-H; Wahlin A; Turesson I; Landgren O
- Journal article: BLOOD. 2009;114(22):1378Derolf ÅR; Andersson TM-L; Lambert PC; Kristinsson SY; Eloranta S; Landgren O; Dickman PW; Bjorkholm M
- Article: OBSTETRICS AND GYNECOLOGY. 2009;114(3):568-572Andersson TM-L; Johansson ALV; Hsieh C-C; Cnattingius S; Lambe M
- Article: VOX SANGUINIS. 2009;96(4):316-323Shanwell A; Andersson TM-L; Rostgaard K; Edgren G; Hjalgrim H; Norda R; Melbye M; Nyren O; Reilly M
- Article: BLOOD. 2009;113(16):3666-3672Derolf AR; Kristinsson SY; Andersson TM-L; Landgren O; Dickman PW; Bjorkholm M
- Article: INTERNATIONAL JOURNAL OF CANCER. 2007;121(9):2052-2059Lambert PC; Dickman PW; Osterlund P; Andersson T; Sankila R; Glimelius B
- Show more
All other publications
- Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024;33:422Szulkin R; Batyrbekova N; Landtblom AR; Dickman P; Hultcrantz M; Andersson T
- Conference publication: EUROPEAN UROLOGY. 2024;85:s52Larsen SB; Lundberg FE; Friis S; Birgisson H; Andersson TML; Engholm G; Lambert PC; Lambe M; Pettersson D; Olafsdottir E; Johannesen TB; Konig SM; Johansson ALV; Morch LS
- Conference publication: ANNALS OF ONCOLOGY. 2023;34:s948Radkiewicz C; Andersson TM-L; Lagergren J
- Conference publication: BLOOD. 2022;140:6856-6857Landtblom AR; Andersson TML; Johansson ALV; Lundberg FE; Samuelsson J; Bjorkholm M; Hultcrantz M
- Preprint: RESEARCH SQUARE. 2022Skourlis N; Crowther M; Andersson TM-L; Lu D; Lambe M; Lambert P
- Preprint: RESEARCH SQUARE. 2022Batyrbekova N; Bower H; Dickman PW; Landtblom AR; Hultcrantz M; Szulkin R; Lambert PC; Andersson TM-L
- Preprint: RESEARCH SQUARE. 2021Rutherford MJ; Andersson TM-L; Myklebust TÅ; Møller B; Lambert PC
- Preprint: RESEARCH SQUARE. 2021Skourlis N; Crowther MJ; Andersson TM-L; Lambert PC
- Preprint: RESEARCH SQUARE. 2021Batyrbekova N; Bower H; Dickman P; Szulkin R; Lambert PC; Andersson TM-L
- Review: JOURNAL OF INTERNAL MEDICINE. 2021;289(1):12-28Eloranta S; Smedby KE; Dickman PW; Andersson TM
- Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:70Brenner P; Brandt L; Nijs M; Reutfors J; Andersson T
- Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:84-85Hagg D; Linder M; Hajiebrahimi M; Song C; Andersson TM-L; Villacorta R
- Conference publication: JOURNAL OF UROLOGY. 2020;203:E247-E248Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
- Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28:99Brenner P; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Reutfors J
- Review: CANCER EPIDEMIOLOGY. 2019;60:168-173Rutherford MJ; Andersson TM-L; Bjorkholm M; Lambert PC
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):e16555Aly M; Schain F; Leval A; Liwing J; Lawson J; Vago E; Nordstrom T; Gronberg H; Andersson TM-L; Sjoland E; Wang C; Eloranta S; Akre O
- Conference publication: BLOOD. 2018;132:930Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fossa A; Andersson TML; Holte HJ; Bogsted M; El-Galaly TC; Smedby KE
- Corrigendum: EUROPEAN JOURNAL OF CANCER. 2017;87:219-220Andersson TM-L; Weiderpass E; Engholm G; Lund A-SQ; Olafsdottir E; Pukkala E; Stenbeck M; Storm H
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S852Reutfors J; Andersson T; Brandt L; Dibernardo A; Li G; Westerlund A; Wingard L; Boden R
- Meeting abstract: BLOOD. 2016;128(22):946Creignou M; Bower H; Andersson TM-L; Landtblom AR; Dickman PW; Bjorkholm M; Kristinsson SY; Hultcrantz M
- Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(24):2851-2857Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
- Conference publication: HAEMATOLOGICA. 2016;101:6-7Landtblom AR; Bower H; Andersson TML; Dickman PW; Bjorkholm M; Kristinsson SY; Hultcrantz M
- Published conference paper: STATISTICS IN MEDICINE. 2016;35(7):1193-1209Crowther MJ; Andersson TM-L; Lambert PC; Abrams KR; Humphreys K
- Conference publication: CANCER RESEARCH. 2016;76:p6-10-07-p6-10-07Lambe M; Johansson ALV; Andersson TM; Hsieh C-C; Cnattingius S; Dickman PW
- Conference publication: BLOOD. 2015;126(23):1605Hultcrantz M; Andersson TM-L; Landgren O; Dickman PW; Andreasson B; Bjorkholm M; Kristinsson SY
- Conference publication: BLOOD. 2015;126(23):2779Bjorkholm M; Bower H; Dickman PW; Lambert PC; Hoglund M; Andersson TM-L
- Meeting abstract: PSYCHONEUROENDOCRINOLOGY. 2015;61:50Lu D; Andersson TM-L; Fall K; Hultman CM; Czene K; Valdimarsdottir U; Fang F
- Conference publication: HAEMATOLOGICA. 2015;100:260-261Hultcrantz M; Lund SH; Andersson TM-L; Bjorkholm M; Kristinsson SY
- Conference publication: HAEMATOLOGICA. 2015;100:193Bower H; Andersson TM-L; Bjorkholm M; Dickman P; Lambert P; Derolf A
- Meeting abstract: BLOOD. 2014;124(21):632Hultcrantz M; Andersson TM-L; Landgren O; Derolf AR; Dickman PW; Bjorkholm M; Kristinsson SY
- Doctoral thesis: 2013Andersson T
- Conference publication: HAEMATOLOGICA. 2013;98:219Bjorkholm M; Eloranta S; Lambert P; Andersson T; Sjoberg J; Dickman P
- Conference publication: CANCER RESEARCH. 2011;71:p1-08-09-p1-08-09Johansson ALV; Andersson TM-L; Cnattingius S; Hsieh C-C; Lambe M
- Conference publication: BLOOD. 2011;118(21):1648-1649Hultcrantz ML; Hinchliffe SR; Kristinsson SY; Andersson TM-L; Eloranta S; Derolf AR; Samuelsson J; Landgren O; Dickman PW; Lambert P; Bjorkholm M
- Conference publication: PEDIATRIC BLOOD & CANCER. 2011;57(5):823Shah A; Andersson T; Rachet B; Burnett A; Lambert P
- Letter: TRANSFUSION. 2011;51(2):445-446Reilly M; Nyren O; Andersson TM-L; Edgren G; Norda R; Shanwell A; Tynell E
- Meeting abstract: BLOOD. 2010;116(21):1266-1267Hultcrantz M; Kristinsson SY; Andersson TM-L; Eloranta S; Derolf AR; Landgren O; Dickman PW; Bjorkholm M
- Conference publication: BLOOD. 2010;116(21):93-94Bjorkholm M; Ohm L; Eloranta S; Derolf AR; Hultcrantz M; Sjoberg J; Andersson T; Hoglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
- Conference publication: HAEMATOLOGICA. 2010;95:470Hultcrantz L; Kristinsson S; Andersson T; Eloranta S; Derolf A; Landgren O; Dickman P; Bjorkholm M
- Conference publication: BLOOD. 2009;114(22):561Derolf AR; Andersson TM-L; Lambert PC; Kristinsson SY; Eloranta S; Landgren O; Dickman PW; Bjorkholm M
- Conference publication: HAEMATOLOGICA. 2009;94:157Kristinsson SY; Bjorkholm M; Andersson TML; Eloranta S; Dickman PW; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
- Scholarly edition:Estimating and modeling cure within the framework of flexible parametric survival modelsAndersson TM-L; Eloranta S; Dickman PW; Lambert PC
- Show more
Selected grants
- Swedish Research Council1 January 2020 - 31 December 2023
- Development of flexible parametric survival models with multiple time-scales – with applications to Myeloproliferative Neoplasm (MPN)Swedish Cancer Society1 January 2019To understand the disease progression and survival after a cancer diagnosis, it is important to fully capture the complex disease pathways that can occur. More advanced statistical methods are needed to be able to do this in the best way. MPN is a chronic blood tumor disease, with 400 new cases in Sweden annually. Despite efforts to optimize treatment and take preventive measures against complications, patients with MPN have poorer survival than the general population and a high risk of complications such as thromboembolism and bleeding. Within this project, I will develop statistical models for survival data with several time scales and several possible outcomes. A major focus will be to enable reporting of the results of complex analyzes in a way that is easy to understand and to develop user-friendly software so that others can use the methods. The utility of the methods will be demonstrated for myeloproliferative neoplasias (MPNs), with unanswered, clinically important research questions. I will use a population-based cohort of MPN patients with long follow-up time and with matched population controls. 1. Measure how the risk of thromboembolism and bleeding among MPN patients changes over time since diagnosis and changes due to the fact that patients age. Determine whether the risk of thromboembolism increases among patients who have had bleeding and whether the risk of bleeding increases among patients who have had thromboembolism. Describe the entire disease chain from MPN to complications of thromboembolism and bleeding, and finally death, and the proportion of patients who suffered from thromboembolism and bleeding, or both, and died over time. 4. Calculate the life expectancy of MPN patients and lost life years.
Grants
- Swedish Research Council1 December 2024 - 30 November 2028Sweden has numerous linkable registers which are a goldmine for research in the medical and social sciences. However, as increasingly more complex research questions are being addressed, there are challenges to correctly and efficiently analyse such data, and further methods development is needed. We aim to develop and apply methods for register-based research that are relevant for a wide range of settings. We also aim to transfer new methodology to subject-matter scientists and train the next generation of biostatistical scientists. The long-term goal is to leverage the rich information within the registers for the benefit of patients, policy-makers and society. Specifically, we will develop, evaluate and apply methods for:1. Missing data in registers2. Causal mediation analysis3. Policy-relevant complex disease models and lifetime outcomes in health economics 4. Federated analyses and synthetic data to share information.Our proposal focuses on the development of statistical methods, but each aim is motivated by real problems in medicine and social science, e.g. improving cancer screening, understanding causal mechanisms for social inequalities in cancer survival, time trends in disease incidence trends and situations when individual-level data cannot cross borders. Our team of biostatistical scientists will work in close collaboration with an extended network of Swedish and Nordic register holders, epidemiologists, clinical and social scientists, and relevant stakeholders.
- Swedish Research Council1 January 2024 - 31 December 2026The prognosis following a diagnosis of cancer, or other diseases, is often measured using survival proportions. Recently, however, there has been an increased interest in presenting other measures of patient survival, that are easier to interpret and can give a better understanding of the impact a diagnosis has on an individual’s life span. I have previously developed such methods, namely methods for estimating the life expectancy for cancer patients and the loss in life expectancy (LLE) compared to cancer-free individuals. To further enhance the usefulness of the measures, further extensions are needed. The aim of this project is to further develop and apply the methods, specifically toCombine causal mediation analysis and LLE to quantify the impact of potential drivers of socioeconomic differences in survivalIncorporate uncertainty in general population mortality in the estimation of LLEInvestigate assumptions in survival extrapolation for estimation of LLEThe developed methods will be applied to cancer registry data, to answer research questions of clinical and public health importance. For example, to investigate socioeconomic inequalities in survival of patients with malignant melanoma and colorectal cancer, to estimate the LLE for hematological cancers with an indolent disease course, as well as for patients diagnosed with malignant melanoma at a young age. The methods have potential to be used also in other disease areas.
- Extensions and applications of loss in life expectancy for cancer patientsCancerfonden1 January 2023 - 31 December 2025
- Swedish Cancer Society1 January 2023The prognosis for cancer patients is often measured using survival rates. Recently, however, there has been increased interest in presenting other measures of cancer patient survival, which are easier to interpret and which can provide a better understanding of the impact a cancer diagnosis has on an individual's lifespan. I have previously developed such methods, namely methods for estimating the average life expectancy of cancer patients and the loss in life expectancy (LLE) compared to cancer-free individuals. In order to further increase the usefulness of the measurements, they need to be further developed. The purpose of this project is to further develop and apply the methods. The new methods will be applied to cancer registry data, to answer research questions of clinical interest and which are important from a public health perspective. For example, to investigate socio-economic inequalities in survival in patients with malignant melanoma and colorectal cancer, to estimate the LLE for hematological cancers with an indolent course of disease, as well as for patients diagnosed with malignant melanoma at a young age. More specifically, I will: - Combining causal analysis and LLE to quantify the impact of potential causes behind socioeconomic disparities in cancer patient survival - Include uncertainty in general population mortality in the estimate of the LLE, so that confidence intervals for the LLE are correctly estimated - Examine assumptions made when estimating LLE, to see in which situations assumptions do not apply and design alternative assumptions
- Swedish Cancer Society1 January 2020To understand the disease progression and survival after a cancer diagnosis, it is important to fully capture the complex disease pathways that can occur. More advanced statistical methods are needed to be able to do this in the best way. MPN is a chronic blood tumor disease, with 400 new cases in Sweden annually. Despite efforts to optimize treatment and take preventive measures against complications, patients with MPN have poorer survival than the general population and a high risk of complications such as thromboembolism and bleeding. Within this project, I will develop statistical models for survival data with several time scales and several possible outcomes. A major focus will be to enable reporting of the results of complex analyzes in a way that is easy to understand and to develop user-friendly software so that others can use the methods. The utility of the methods will be demonstrated for myeloproliferative neoplasias (MPNs), with unanswered, clinically important research questions. I will use a population-based cohort of MPN patients with long follow-up time and with matched population controls. 1. Measure how the risk of thromboembolism and bleeding among MPN patients changes over time since diagnosis and changes due to the fact that patients age. Determine whether the risk of thromboembolism increases among patients who have had bleeding and whether the risk of bleeding increases among patients who have had thromboembolism. Describe the entire disease chain from MPN to complications of thromboembolism and bleeding, and finally death, and the proportion of patients who suffered from thromboembolism and bleeding, or both, and died over time. 4. Calculate the life expectancy of MPN patients and lost life years.
Employments
- Senior Lecturer, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2020-
- Postdoctoral Researcher, Danish Cancer Society, 2015-2016
Degrees and Education
- Docent, Karolinska Institutet, 2020
- Degree Of Doctor Of Philosophy, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2013
- MSc, Mathematical Statistics, Uppsala University, 2007